Practical Approach to the Diagnosis and Treatment of Anemia Associated With CKD in Elderly

Journal of the American Medical Directors Association

Volumn 7, Issue 9 SUPPL., 2006, Pages

  Agarwal, Anil K ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Anemia; chronic kidney disease; erythropoiesis stimulating protein (ESP); hemoglobin; treatment; treatment strategies

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; ERYTHROPOIETIN; FERRITIN; FERROUS SULFATE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

AGED; ANEMIA; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DRUG ABSORPTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; DRUG RESPONSE; DRUG SAFETY; DRUG TREATMENT FAILURE; ERYTHROPOIESIS; FOLLOW UP; GASTROINTESTINAL TOXICITY; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HEMOGLOBINOPATHY; HOSPITALIZATION; HUMAN; HYPERTENSION; INFLAMMATORY DISEASE; IRON DEFICIENCY; IRON STORAGE; IRON THERAPY; MORTALITY; MUSCLE MASS; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PATIENT MONITORING; POSTMENOPAUSE; PRACTICE GUIDELINE; PROTEIN DEFICIENCY; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; SEIZURE; THROMBOSIS; UNITED STATES;

EID: 33750628638     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2006.09.005     Document Type: Article

References (28)

1. American Heart Association. Heart disease and stroke statistics (2006) update
2. Hunsicker L.G., and Levey A.S. Progression of chronic renal disease: mechanisms, risk factors, and testing of interventions. In: Jacobson H.R., Striker G.E., and Klahr S. (Eds). The Principles and Practice of Nephrology (1995), Mosby, Philadelphia, PA 622-631
3. Esbach J.W., and Adamson J.W. Anemia of end-stage renal disease 28 (1985) 1-5
4. MacDougall I.C. Role of uremic toxins in exacerbating anemia in renal failure. Kidney Int 78 Suppl (2001) S67-S72
5. KEEP: Kidney Early Evaluation Program. Annual Data Report. Am J Kidney Dis 42 Suppl 4 (2003) S1-S60
6. Eschbach J.W., Varma A., and Stivelman J.C. Is it time for a paradigm shift?. Is erythropoietin deficiency still the main cause of renal anaemia? Nephrol Dial Transplant 17 Suppl 5 (2002) 2-7
7. Radtke H.W., Claussner A., Erbes P.M., et al. Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. Blood 54 (1979) 877-884
8. Obrador G.T., Ruthazer R., and Arora P. Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol 10 (1999) 1793-1800
9. Nurko S. Anemia in chronic kidney disease: causes, diagnosis, treatment. Cleveland Clinic J Med 3 (2006) 289-297
10. Brenner B.M., Cooper M.E., and de Zeeuw D. The losartan renal protection study: rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with Angiotensin II Antagonist Losartan). J Ren Ang Ald Sys 1 (2000) 328-335
11. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis 37 1 Suppl 1 (2001) S182-S238
12. Locatelli F., Aljama P., Bárány P., et al. European Best Practice Guidelines Working Group. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 19 Suppl 2 (2004) ii1-ii5
13. WHO/UNICEF/UNU. Iron deficiency anaemia: assessment, prevention, and control (2001), WHO, Geneva, Switzerland
14. Schwartz A., Prasad V., and Garcha J. Anemia of chronic kidney disease: A combined effect of marginal iron stores and erythropoietin deficiency. Dialysis Transplant 33 (2004) 758-767
15. Rimon E., Kagansky N., Kagansky M., et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med 118 (2005) 1142-1147
16. Schaefer R.M., and Bahner U. Iron metabolism in rhEPO-treated hemodialysis patients. Clin Nephrol 53 Suppl (2000) S65-S68
17. Elliot S., Lorenzini T., Asher S., et al. Enhancement of therapeutic protein in vivo activities through glycoengineering. Nat Biotechnol 21 (2003) 414-421
18. Erythropoetin (Epogen/Procrit) [package insert]. Raritan (NJ): Ortho Biotech Products, LP; 2005. Available at: http://www.epogen.com/pdf/epogen_pi.pdf. Accessed August 16, 2006.
19. Darbepoetin (Aranesp) [package insert]. Thousand Oaks (CA): Amgen Inc.; 2005.Available at: http://www.aranesp.com/pdf/aranesp_PI.pdf Accessed August 16, 2006.
20. Jadoul M., Vanrenterghem Y., Foret M., et al., Darbepoetin Alfa 20000144 Study Group. Darbepoetin alfa administered once monthly maintains haemoglobin levels in stable dialysis patients. Nephrol Dial Transplant 19 (2004) 898-903
21. Agarwal A., Ling B., Wacky M., et al. Aranesp (darbepoetin alfa) administered once monthly maintains hemoglobin levels in patient with chronic kidney disease (CKD) (2004) Presented at: Annual Meeting of the National Kidney Foundation Clinical Nephrology; April 28-May 2, Chicago, IL.
22. Fink J., Provenzano R., Woodman R., Hill K., et al. Comparative analysis of efficacy and safety of once-weekly (QW) epoetin alfa (EPO) in elderly (≥65) and non-elderly (<65) patients with anemia due to chronic kidney disease (CKD). J Am Geriatr Soc 52 Suppl 1 (2004) s25
23. Provenzano R., Bhaduri S., Singh A.K., and PROMPT Study Group. Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: The PROMPT study. Clin Nephrol 64 (2005) 113-123
24. Hertel J., Locay H., Scarlata D., et al. Darbepoetin alfa administered every other week maintains hemoglobin levels over 52 weeks in patients with chronic kidney disease converting from once-weekly recombinant human erythropoietin: results from Simplify the Treatment of Anemia with Aranesp (STAAR). Am J Nephrol 26 (2006) 149-156
25. Ling B., Agarwal A., Scarlata D., Liu W., Brenner R., and Audhya P. Once-monthly Aranesp (darbepoetin alfa) maintains hemoglobin in elderly chronic kidney disease patients (2005) Poster presented at: American Geriatrics Society Annual Scientific Meeting; Orlando, FL.
26. Ling B., Walczyk M., Agarwal A., et al. Darbepoetin alfa administered once monthly maintains hemoglobin concentrations in patients with chronic kidney disease. Clin Nephrol 63 (2005) 327-334
27. Agarwal A, Silver MR, Walczyk M, Liu W, Audhy P. Once-monthly darbepoetin alfa for maintaining hemoglobin levels in older patients with chronic kidney disease. J Am Med Dir Assoc; in press.
28. Radtke H.W., Claussner A., and Erbes P.M. Serum erythropoietin concentration in chronic renal failure: Relationship to degree of anemia and excretory function. Blood 54 (1979) 877-884